Designing adjuvant studies for intraperitoneal therapy can use peritoneal recurrence control as an endpoint instead of survival. This approach impacts study sample size and implementation strategies for peritoneal surface disease.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: